Cell-specific nanoplatform-enabled photodynamic therapy for cardiac cells

Heart Rhythm

Volumn 9, Issue 9, 2012, Pages 1504-1509

  Avula, Uma Mahesh R ^a   Kim, Gwangseong ^b   Lee, Yong Eun Koo ^b   Morady, Fred ^a   Kopelman, Raoul ^b   Kalifa, Jrme ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Arrhythmia; Methylene blue; Nanoparticle; Photodynamic therapy; Targeted ablation

Indexed keywords

MACROGOL; METHYLENE BLUE; NANOPARTICLE; PHOTOSENSITIZING AGENT; POLYACRYLAMIDE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CATHETER ABLATION; CELL CULTURE; COCULTURE; CONJUGATION; FIBROBLAST CULTURE; HEART MUSCLE CELL; HEART VENTRICLE; IN VITRO STUDY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANIMALS; ELECTROCARDIOGRAPHY; FEASIBILITY STUDIES; MYOCYTES, CARDIAC; MYOFIBROBLASTS; NANOPARTICLES; PHOTOCHEMOTHERAPY; RATS; REACTIVE OXYGEN SPECIES;

EID: 84865633752     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.05.011     Document Type: Article

References (35)

1. H. Oral, C. Scharf, A. Chugh Catheter ablation for paroxysmal atrial fibrillation Circulation 108 2003 2355 2360
2. F. Morady, M.M. Sgheinman Transvenous catheter ablation of a posteroseptal accessory pathway in a patient with the WolffParkinsonWhite syndrome N Engl J Med 310 1984 705 707
3. H. Calkins, J. Brugada, D.L. Packer HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society Europace 9 2007 335 379
4. A. Castao, T. Crawford, M. Yamazaki, U.M.R. Avula, J. Kalifa Coronary artery pathophysiology after radiofrequency catheter ablation: review and perspectives Heart Rhythm 8 2011 1975 1980
5. R. Cappato, H. Calkins, S.A. Chen Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation Circulation 111 2005 1100 1105
6. C. Pappone, H. Oral, V. Santinelli Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation Circulation 109 2004 2724 2726
7. E. Sosa, M. Scanavacca Left atrial-esophageal fistula complicating radiofrequency catheter ablation of atrial fibrillation J Cardiovasc Electrophysiol 16 2005 249 250
8. I.M. Robbins, E.V. Colvin, T.P. Doyle Pulmonary vein stenosis after catheter ablation of atrial fibrillation Circulation 98 1998 1769 1775
9. L. Yang, Y. Wei, D. Xing, Q. Chen Increasing the efficiency of photodynamic therapy by improved light delivery and oxygen supply using an anticoagulant in a solid tumor model LASERs Surg Med 42 2010 671 679
10. D.E. Dolmans, R.K.J. Dai Fukumura Photodynamic therapy for cancer Nat Rev Cancer 3 2003 380 387
11. B. Ross, A. Rehemtulla, Y.E.L. Koo Photonic and magnetic nanoexplorers for biomedical use: from subcellular imaging to cancer diagnostics and therapy SPIE (International Society of Photonic Engineering) 5331 2004 76 83
12. P.A. Suci, Z. Varpness, E. Gillitzer, T. Douglas, M. Young Targeting and photodynamic killing of a microbial pathogen using protein cage architectures functionalized with a photosensitizer Langmuir 23 2007 12280 12286
13. P. Couleaud, V. Morosini, C. Frochot, S. Richeter, L. Raehm, J.O. Durand Silica-based nanoparticles for photodynamic therapy applications Nanoscale 2 2010 1083 1095
14. B. Chen, B.W. Pogue, P.J. Hoopes, T. Hasan Vascular and cellular targeting for photodynamic therapy Crit Rev Eukaryot Gene Expr 16 2006 279 305
15. M. Zahid, B.E. Phillips, S.M. Albers, N. Giannoukakis, S.C. Watkins, P.D. Robbins Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in mice PLoS One 5 2010 e12252
16. H.J. Hah, G. Kim, Y.E.K. Lee Methylene blueconjugated hydrogel nanoparticles and tumorcell targeted photodynamic therapy Macromol Biosci 11 2011 90 99
17. D. Severino, H.C. Junqueira, M. Gugliotti, D.S. Gabrielli, M.S. Baptista Influence of negatively charged interfaces on the ground and excited state properties of methylene blue Photochem Photobiol 77 2003 459 468
18. R. Vaidyanathan, S.M. Taffet, K.L. Vikstrom, J. Anumonwo Regulation of cardiac inward rectifier potassium current (I(K1)) by synapse-associated protein-97 J Biol Chem 285 2010 28000 28009
19. A.B. Gustafsson, L.L. Brunton Beta-adrenergic stimulation of rat cardiac fibroblasts enhances induction of nitric-oxide synthase by interleukin-1 beta via message stabilization Mol Pharmacol 58 2000 1470 1478
20. E.S. Kaneshiro, M.A. Wyder, Y.P. Wu, M.T. Cushion Reliability of calcein acetoxymethyl ester and ethidium homodimer or propidium iodide for viability assessment of microbes J Microbiol Meth 17 1993 1 16
21. A. Ito, S. Hosokawa, S. Miyoshi, K. Soejima, S. Ogawa, T. Arai The myocardial electrical blockade induced by photosensitization reaction IEEE Trans Biomed Eng 57 2010 488 495
22. S. Miyoshi, A. Itoh, T. Kajihara Cavo-tricuspid isthmus ablation by novel photodynamic LASER catheter in swine heart in vivo J Am Coll Cardiol 55 2010 A7 E70
23. S. Hettiaratchy, J. Clarke, J. Taubel, C. Besa Burns after photodynamic therapy BMJ 320(7244) 2000 May 6 1245
24. M.A. D'hallewin, L. Baert Bladder spectrophotometry after intravesical Epirubicine instillations: evaluation of future possibilities of topical bladder sensitization for PDT LASERs Med Sci 5 1990 13 15
25. D. Shah, J.M. Dumonceau, H. Burri Acute pyloric spasm and gastric hypomotility: an extracardiac adverse effect of percutaneous radiofrequency ablation for atrial fibrillation J Am Coll Cardiol 46 2005 327 330
26. D.A. Orringer, T. Chen, D.L. Huang The brain tumor window model: a combined cranial window and implanted glioma model for evaluating intraoperative contrast agents Neurosurgery 66 2010 736 743
27. I. Winer, S. Wang, Y.E.K. Lee F3-targeted cisplatin-hydrogel nanoparticles as an effective therapeutic that targets both murine and human ovarian tumor endothelial cells in vivo Cancer Res 70 2010 8674 8683
28. P.J. Podrid Proarrhythmia, a serious complication of antiarrhythmic drugs Curr Cardiol Rep 1 1999 289 296
29. G.V. Naccarelli, D.L. Wolbrette, L. Bhatta A review of clinical trials assessing the efficacy and safety of newer antiarrhythmic drugs in atrial fibrillation J Interv Card Electrophysiol 9 2003 215 222
30. M.A. Vos Atrialspecific drugs J Cardiovasc Electrophysiol 15 2004 1451 1452
31. Y. Blaauw, U. Schotten, A. Van Hunnik, H. Neuberger, M. Allessie Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat Cardiovasc Res 75 2007 89
32. J.K. Vasir, V. Labhasetwar Preparation of biodegradable nanoparticles and their use in transfection CSH Protoc 2008 2010 pdb. prot4888
33. P. Shum, J.M. Kim, D.H. Thompson Phototriggering of liposomal drug delivery systems Adv Drug Delivery Rev 53 2001 273 284
34. Y. Cheng, A. C Samia, J.D. Meyers, I. Panagopoulos, B. Fei, C. Burda Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer J Am Chem Soc 130 2008 10643 10647
35. L. Yue, J. Xie, S. Nattel Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation Cardiovasc Res 89 2011 744 753